Search Results 611-620 of 16033 for syphilis
Targeting cells. Dr. Barry's team engineers new ways to get genes into cells and amplify those genes and the proteins that they produce.
About this study. This Registry will enroll cirrhotic participants with or without decompensated liver disease who have achieved a sustained virologic ...
Behavioral interventions currently provide the most useful approach to addressing the behavioral and social needs of those with Mild Cognitive Impairment (MCI) ...
The purpose of this study is to define the determinants of cirrhosis progression using clinical and specialized biomarkers over time in North America through a ...
About this study. The first double-blind 72-week treatment period will assess the efficacy and safety of elafibranor on the resolution of NASH without ...
The Vaccine Research Group at Mayo Clinic provides teaching opportunities to undergraduate, graduate, medical and postdoctoral students.
Diagnosis A health care provider will likely make a probable diagnosis of plague based on: Symptoms. Possible exposure to the disease during recent outdoor ...
McLeod is Board-Certified in Adult Congenital Heart Disease as well as Cardiac Electrophysiology. He uniquely straddles these disciplines to care for an ever- ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.